Balchem Net Worth
Balchem Net Worth Breakdown | BCPC |
Balchem Net Worth Analysis
Balchem's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Balchem's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Balchem's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Balchem's net worth analysis. One common approach is to calculate Balchem's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Balchem's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Balchem's net worth. This approach calculates the present value of Balchem's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Balchem's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Balchem's net worth. This involves comparing Balchem's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Balchem's net worth relative to its peers.
Enterprise Value |
|
To determine if Balchem is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Balchem's net worth research are outlined below:
| Balchem generated a negative expected return over the last 90 days | |
| Balchem is unlikely to experience financial distress in the next 2 years | |
| Balchem has a strong financial position based on the latest SEC filings | |
| Over 91.0% of the company shares are held by institutions such as insurance companies | |
| On 17th of January 2025 Balchem paid $ 0.87 per share dividend to its current shareholders | |
| Latest headline from news.google.com: US Bancorp DE Has 1.06 Million Stock Position in Balchem Co. - Defense World |
Balchem Quarterly Good Will |
|
Balchem uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Balchem. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Balchem's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 23rd of February 2024 Upcoming Quarterly Report | View | |
| 26th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 23rd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Balchem Target Price Consensus
Balchem target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Balchem's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Buy |
Most Balchem analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Balchem stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Balchem, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationBalchem Target Price Projection
Balchem's current and average target prices are 167.72 and 190.33, respectively. The current price of Balchem is the price at which Balchem is currently trading. On the other hand, Balchem's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Balchem Target Price
Know Balchem's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Balchem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Balchem backward and forwards among themselves. Balchem's institutional investor refers to the entity that pools money to purchase Balchem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-12-31 | 509.5 K | Norges Bank | 2024-12-31 | 430.5 K | Northern Trust Corp | 2024-12-31 | 407.1 K | Charles Schwab Investment Management Inc | 2024-12-31 | 370.9 K | Clearbridge Advisors, Llc | 2024-12-31 | 368.3 K | Schroder Investment Management Group | 2024-12-31 | 367.2 K | Congress Asset Management Company, Llp | 2024-12-31 | 317.6 K | Stephens Inv Mgmt Group Llc | 2024-12-31 | 278.9 K | William Blair Investment Management, Llc | 2024-12-31 | 274.5 K | Blackrock Inc | 2024-12-31 | 5.2 M | Vanguard Group Inc | 2024-12-31 | 4 M |
Follow Balchem's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.46 B.Market Cap |
|
Project Balchem's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.20 | 0.12 | |
| Return On Capital Employed | 0.13 | 0.21 | |
| Return On Assets | 0.08 | 0.11 | |
| Return On Equity | 0.11 | 0.17 |
When accessing Balchem's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Balchem's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Balchem's profitability and make more informed investment decisions.
Please note, the presentation of Balchem's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Balchem's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Balchem's management manipulating its earnings.
Evaluate Balchem's management efficiency
Balchem has return on total asset (ROA) of 0.0725 % which means that it generated a profit of $0.0725 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1166 %, meaning that it created $0.1166 on every $100 dollars invested by stockholders. Balchem's management efficiency ratios could be used to measure how well Balchem manages its routine affairs as well as how well it operates its assets and liabilities. At present, Balchem's Return On Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.17, whereas Return On Tangible Assets are forecasted to decline to 0.12. At present, Balchem's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 329.5 M, whereas Other Current Assets are forecasted to decline to about 7.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 35.57 | 37.34 | |
| Tangible Book Value Per Share | 6.34 | 6.65 | |
| Enterprise Value Over EBITDA | 28.75 | 30.18 | |
| Price Book Value Ratio | 4.58 | 2.98 | |
| Enterprise Value Multiple | 28.75 | 30.18 | |
| Price Fair Value | 4.58 | 2.98 | |
| Enterprise Value | 4.5 B | 4.8 B |
Effective leadership at Balchem drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 5.8903 | Revenue | Quarterly Revenue Growth 0.049 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Balchem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Balchem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Balchem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Balchem Corporate Filings
8K | 3rd of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 14th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of February 2025 Other Reports | ViewVerify | |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Balchem Earnings Estimation Breakdown
The calculation of Balchem's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Balchem is estimated to be 1.215 with the future projection ranging from a low of 1.18 to a high of 1.25. Please be aware that this consensus of annual earnings estimates for Balchem is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.18 Lowest | Expected EPS | 1.25 Highest |
Balchem Earnings Projection Consensus
Suppose the current estimates of Balchem's value are higher than the current market price of the Balchem stock. In this case, investors may conclude that Balchem is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Balchem's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 2 | 89.9% | 1.13 | 1.215 | 3.93 |
Balchem Earnings History
Earnings estimate consensus by Balchem analysts from Wall Street is used by the market to judge Balchem's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Balchem's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Balchem Quarterly Gross Profit |
|
Balchem Earnings per Share Projection vs Actual
Actual Earning per Share of Balchem refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Balchem predict the company's earnings will be in the future. The higher the earnings per share of Balchem, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Balchem Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Balchem, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Balchem should always be considered in relation to other companies to make a more educated investment decision.Balchem Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Balchem's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-14 | 2024-12-31 | 1.105 | 1.13 | 0.025 | 2 | ||
2024-10-25 | 2024-09-30 | 1.11 | 1.13 | 0.02 | 1 | ||
2024-07-26 | 2024-06-30 | 1.03 | 1.09 | 0.06 | 5 | ||
2024-05-03 | 2024-03-31 | 0.98 | 1.03 | 0.05 | 5 | ||
2024-02-16 | 2023-12-31 | 0.93 | 0.95 | 0.02 | 2 | ||
2023-10-27 | 2023-09-30 | 0.97 | 1.04 | 0.07 | 7 | ||
2023-07-28 | 2023-06-30 | 0.84 | 1.06 | 0.22 | 26 | ||
2023-04-28 | 2023-03-31 | 0.7 | 0.94 | 0.24 | 34 | ||
2023-02-24 | 2022-12-31 | 0.83 | 0.94 | 0.11 | 13 | ||
2022-11-04 | 2022-09-30 | 0.85 | 1.0 | 0.15 | 17 | ||
2022-07-29 | 2022-06-30 | 0.91 | 1.07 | 0.16 | 17 | ||
2022-04-29 | 2022-03-31 | 0.79 | 1.03 | 0.24 | 30 | ||
2022-02-18 | 2021-12-31 | 0.85 | 0.85 | 0.0 | 0 | ||
2021-10-29 | 2021-09-30 | 0.9 | 0.92 | 0.02 | 2 | ||
2021-07-30 | 2021-06-30 | 0.88 | 0.93 | 0.05 | 5 | ||
2021-04-30 | 2021-03-31 | 0.85 | 0.87 | 0.02 | 2 | ||
2021-02-19 | 2020-12-31 | 0.81 | 0.83 | 0.02 | 2 | ||
2020-10-28 | 2020-09-30 | 0.7 | 0.83 | 0.13 | 18 | ||
2020-07-31 | 2020-06-30 | 0.56 | 0.85 | 0.29 | 51 | ||
2020-05-01 | 2020-03-31 | 0.61 | 0.81 | 0.2 | 32 | ||
2020-02-21 | 2019-12-31 | 0.84 | 0.88 | 0.04 | 4 | ||
2019-11-05 | 2019-09-30 | 0.74 | 0.81 | 0.07 | 9 | ||
2019-08-01 | 2019-06-30 | 0.72 | 0.77 | 0.05 | 6 | ||
2019-05-03 | 2019-03-31 | 0.64 | 0.73 | 0.09 | 14 | ||
2019-02-28 | 2018-12-31 | 0.69 | 0.77 | 0.08 | 11 | ||
2018-11-06 | 2018-09-30 | 0.65 | 0.73 | 0.08 | 12 | ||
2018-08-03 | 2018-06-30 | 0.76 | 0.76 | 0.0 | 0 | ||
2018-05-04 | 2018-03-31 | 0.71 | 0.76 | 0.05 | 7 | ||
2018-02-27 | 2017-12-31 | 0.62 | 0.68 | 0.06 | 9 | ||
2017-11-07 | 2017-09-30 | 0.62 | 0.63 | 0.01 | 1 | ||
2017-08-04 | 2017-06-30 | 0.63 | 0.64 | 0.01 | 1 | ||
2017-05-09 | 2017-03-31 | 0.61 | 0.59 | -0.02 | 3 | ||
2017-02-28 | 2016-12-31 | 0.65 | 0.67 | 0.02 | 3 | ||
2016-11-04 | 2016-09-30 | 0.65 | 0.61 | -0.04 | 6 | ||
2016-08-05 | 2016-06-30 | 0.65 | 0.66 | 0.01 | 1 | ||
2016-05-10 | 2016-03-31 | 0.62 | 0.58 | -0.04 | 6 | ||
2016-02-29 | 2015-12-31 | 0.56 | 0.66 | 0.1 | 17 | ||
2015-11-03 | 2015-09-30 | 0.61 | 0.61 | 0.0 | 0 | ||
2015-08-04 | 2015-06-30 | 0.56 | 0.62 | 0.06 | 10 | ||
2015-05-05 | 2015-03-31 | 0.59 | 0.62 | 0.03 | 5 | ||
2015-02-24 | 2014-12-31 | 0.61 | 0.61 | 0.0 | 0 | ||
2014-11-10 | 2014-09-30 | 0.51 | 0.49 | -0.02 | 3 | ||
2014-08-08 | 2014-06-30 | 0.46 | 0.31 | -0.15 | 32 | ||
2014-05-05 | 2014-03-31 | 0.37 | 0.29 | -0.08 | 21 | ||
2014-02-27 | 2013-12-31 | 0.36 | 0.35 | -0.01 | 2 | ||
2013-11-05 | 2013-09-30 | 0.41 | 0.38 | -0.03 | 7 | ||
2013-07-31 | 2013-06-30 | 0.39 | 0.38 | -0.01 | 2 | ||
2013-05-03 | 2013-03-31 | 0.37 | 0.36 | -0.01 | 2 | ||
2013-02-21 | 2012-12-31 | 0.34 | 0.33 | -0.01 | 2 | ||
2012-11-02 | 2012-09-30 | 0.35 | 0.36 | 0.01 | 2 | ||
2012-08-01 | 2012-06-30 | 0.31 | 0.33 | 0.02 | 6 | ||
2012-05-02 | 2012-03-31 | 0.33 | 0.31 | -0.02 | 6 | ||
2012-02-27 | 2011-12-31 | 0.36 | 0.31 | -0.05 | 13 | ||
2011-11-02 | 2011-09-30 | 0.33 | 0.36 | 0.03 | 9 | ||
2011-08-03 | 2011-06-30 | 0.31 | 0.32 | 0.01 | 3 | ||
2011-05-03 | 2011-03-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2011-02-28 | 2010-12-31 | 0.29 | 0.31 | 0.02 | 6 | ||
2010-10-29 | 2010-09-30 | 0.27 | 0.29 | 0.02 | 7 | ||
2010-08-03 | 2010-06-30 | 0.27 | 0.28 | 0.01 | 3 | ||
2010-05-04 | 2010-03-31 | 0.25 | 0.24 | -0.01 | 4 | ||
2010-02-25 | 2009-12-31 | 0.2 | 0.24 | 0.04 | 20 | ||
2009-10-29 | 2009-09-30 | 0.19 | 0.24 | 0.05 | 26 | ||
2009-07-30 | 2009-06-30 | 0.19 | 0.24 | 0.05 | 26 | ||
2009-02-24 | 2008-12-31 | 0.17 | 0.17 | 0.0 | 0 | ||
2008-10-30 | 2008-09-30 | 0.18 | 0.17 | -0.01 | 5 | ||
2008-07-31 | 2008-06-30 | 0.17 | 0.17 | 0.0 | 0 | ||
2008-05-08 | 2008-03-31 | 0.16 | 0.17 | 0.01 | 6 | ||
2008-03-04 | 2007-12-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2007-11-05 | 2007-09-30 | 0.15 | 0.16 | 0.01 | 6 | ||
2007-08-01 | 2007-06-30 | 0.13 | 0.15 | 0.02 | 15 | ||
2007-05-09 | 2007-03-31 | 0.12 | 0.13 | 0.01 | 8 | ||
2007-02-23 | 2006-12-31 | 0.11 | 0.11 | 0.0 | 0 | ||
2006-10-31 | 2006-09-30 | 0.11 | 0.12 | 0.01 | 9 | ||
2006-08-01 | 2006-06-30 | 0.12 | 0.11 | -0.01 | 8 | ||
2006-05-01 | 2006-03-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2006-02-17 | 2005-12-31 | 0.11 | 0.1 | -0.01 | 9 | ||
2005-04-28 | 2005-03-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2005-02-15 | 2004-12-31 | 0.09 | 0.08 | -0.01 | 11 | ||
2004-10-26 | 2004-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2004-07-27 | 2004-06-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2004-04-27 | 2004-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2003-10-28 | 2003-09-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2003-07-28 | 2003-06-30 | 0.07 | 0.07 | 0.0 | 0 | ||
2003-04-29 | 2003-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2003-02-12 | 2002-12-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2002-12-02 | 2002-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2001-08-08 | 2001-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2001-05-02 | 2001-03-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2001-02-12 | 2000-12-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2000-10-23 | 2000-09-30 | 0.04 | 0.04 | 0.0 | 0 |
Balchem Corporate Management
| Hatsuki Miyata | General VP | Profile | |
| William CPA | VP Officer | Profile | |
| Frederic Boned | Senior Health | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Brent Tignor | Senior Officer | Profile | |
| Carl Bengtsson | CFO Treasurer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.258 | Dividend Share 0.87 | Earnings Share 3.93 | Revenue Per Share | Quarterly Revenue Growth 0.049 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.